| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8786232 | Clinical Oncology | 2018 | 8 Pages |
Abstract
PD-1 positivity in the tumour nest could be a strong predictor for a worse clinical outcome and may be a useful indicator for selecting appropriate candidates for adjuvant therapy such as chemotherapy in upper tract urothelial carcinoma patients treated with radical nephroureterectomy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
N. Hayakawa, E. Kikuchi, S. Mikami, K. Fukumoto, M. Oya,